CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2017; 75(03): 137-138
Cerebellar ataxia associated with anti-glutamic acid decarboxylase (anti-GAD) autoantibodies: a rare and puzzling disease
Ataxia cerebelar associada com anticorpos anti-GAD: uma rara e enigmática doença
Hélio A. G. Teive
1
Universidade Federal do Paraná, Hospital de Clínicas, Unidade de Distúrbios do Movimento, Departamento de Medicina Interna, Serviço de Neurologia, Curitiba PR, Brasil.
› Institutsangaben
References
1 Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008;131(10):2553-63. https://doi.org/10.1093/brain/awn183
2 Fernandes M, Munhoz RP, Carrilho PE, Arruda WO, Lorenzoni PJ, Scola RH et al. Neurological disorders associated with glutamic acid decarboxylase antibodies: a Brazilian series. Arq Neuropsiquiatr. 2012;70(9):657-61. https://doi.org/10.1590/S0004-282X2012000900002
3 Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS et al. Consensus paper: neuroimmune mechanisms of cerebellar ataxias. Cerebellum. 2016;15(2):213-32. https://doi.org/10.1007/s12311-015-0664-x
4 Sarva H, Deik A, Ullah A, Severt WL. Clinical spectrum of stiff person syndrome: A review of recent reports. Tremor Other Hyperkinet Mov (N Y). 2016;6:340. . https://doi.org/10.7916/D85M65GD
5 Moersch FP, Woltman HW. Progressive fluctuating muscular rigidity and spasm (“stiff-man” syndrome): report of a case and some observations in 13 other cases. Proc Staff Meet Mayo Clin. 1956;25:421-7.
6 Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz JJ, Tolosa E et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin diabetes mellitus, and polyendocrine autoimmunity. Neurology. 1997;49(4):1026-30. https://doi.org/10.1212/WNL.49.4.1026
7 Abele M, Weller M, Mescheriakov S, Bürk K, Dichgans J, Klockgether T. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Neurology. 1999;52(4):857-9. https://doi.org/10.1212/WNL.52.4.857
8 Pedroso JL, Braga-Neto P, Dutra LA, Barsottini OG. Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy. Arq Neuropsiquiatr. 2011;69(6):993. https://doi.org/10.1590/S0004-282X2011000700030
9 Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, Andres C et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol. 2001;58(2):225-30. https://doi.org/10.1001/archneur.58.2.225
10 Mitoma H, Hadjivassiliou M, Honnorat J. Guidelines for treatment of immune-mediated cerebellar ataxias. Cerebellum Ataxias. 2015;2(1):14. https://doi.org/10.1186/s40673-015-0034-y
11 Hadjivassiliou M, Boscolo S, Tongiorgi E, Grünewald RA, Sharrack B, Sanders DS et al. Cerebellar ataxia as a possible organ-specific autoimmune disease. Mov Disord. 2008;23(10):1270-7. https://doi.org/10.1002/mds.22129
12 Aguiar T, Fragoso A, Albuquerque CR, et al. Clinical characteristics of patients with cerebellar ataxia associated with anti-GAD antibodies. Arq Neuropsiquiatr 2017;75(3):142-46. https://doi.org/10.1590/0004-282X20170011
